15/10/2025
易新引航 中荃聚力 | 易新材料成功引入中荃控股作為戰略投資者
強強聯合，開啟抗菌新材料市場新篇章
2025年10月10日，香港 : 一場意義深遠的戰略投資簽約儀式在香港理工大學知識轉移與創業處（KTEO）隆重舉行。由香港理工大學科研團隊創立的易新材料有限公司正式宣佈引入中荃控股公司作為戰略投資夥伴，這一合作將為企業發展注入新動力。
本次合作不僅為易新材料公司研發的IMU+®有機抗菌材料打開了新的市場空間，更標誌著兩家企業在科技創新與市場拓展上達成了深度共識。中荃控股公司將借助其豐富的行業資源，引入寶利特皮革、新興石英石等知名供應商品牌，共同開拓抗菌皮革和石材材料的新應用領域。
攜手共贏，打造抗菌材料新生態
簽約儀式上，易新材料有限公司主席盧君宇教授表示：“我們很高興引入實力與經驗並重的中荃控股公司作為戰略投資夥伴。公司未來將聚焦醫療、嬰幼與銀髮族的抗菌市場，中荃的加入將幫助我們開拓更多不同的應用與市場。香港會繼續擔當研發總部與認證中心的角色，中港優勢互相配合，相得益彰。”
中荃控股公司CEO陳又誠先生對合作充滿信心：“我們對IMU+®有機抗菌材料充滿信心，我們將協助易新組建內地分公司，並把IMU+®的應用範圍從原來的3D打印材料擴充到皮革與石材領域，也歡迎其他業界共同探討開發其他新一代的抗菌材料。”
科技創新，引領健康新風向
易新材料有限公司自2021年由香港理工大學的盧君宇教授與簡志偉教授創立以來，一直致力於醫療衛生科學領域的研究。團隊成功研發的IMU+®有機無金屬抗菌材料，能有效滅殺物件上的細菌、病毒與黴菌，降低感染與傳播風險。
目前，添加IMU+®的抗菌3D打印產品已經成功入駐香港醫管局旗下醫院的深切治療部與香港政府的辦事處與公共空間，為公眾衛生與健康保駕護航。這項創新技術正在為我們的日常生活提供更加安全、健康的保障。
戰略佈局，共創未來
中荃控股有限公司自2023年成立以來，一直以“深耕福建，聯通世界”為使命，業務涵蓋新一代辦公空間、地區商貿、青年文旅、資本與孵化四大板塊。此次與易新材料的合作，正是其戰略佈局的重要一環。
易新材料將繼續堅持科技創新驅動企業健康、可持續發展，細化產銷銜接，重視產品品質，走科技創新型、資源節約型和環境友好型的可持續發展之路。這次與中荃控股的合作，將進一步提升企業在市場中的競爭力。
展望未來，雙方將充分發揮各自優勢，共同推動抗菌材料技術的創新與應用，為全球健康事業貢獻更多力量。
Immune Materials Leads, Central Glory Unites | Immune Materials Limited (IML) Successfully Introduces Central Glory Holdings (CGH) as Strategic Investor
A Powerful Alliance to Launch a New Chapter in the Antibacterial Materials Market
October 10, 2025, Hong Kong: A significant strategic investment signing ceremony was held at the Knowledge Transfer and Entrepreneurship Office (KTEO) of The Hong Kong Polytechnic University. Immune Materials Limited (IML), founded by the research team from The Hong Kong Polytechnic University, officially announced the introduction of Central Glory Holdings (CGH) as a strategic investment partner, injecting new momentum into the company’s development.
This collaboration not only opens new market opportunities for IML’s proprietary IMU+® organic-based antibacterial raw material but also marks a deep consensus between the two companies in technological innovation and market expansion. CGH will leverage its extensive industry resources, introducing well-known supplier brands such as Polytech Leather and Xinxing Quartz Stone, to jointly explore new applications in antibacterial leather and stone materials.
Win-Win Partnership to Build a New Ecosystem for Antibacterial Materials
At the signing ceremony, Professor Chris K. Y. Lo, Chairman of Immune Materials Limited (IML), stated: “We are delighted to welcome Central Glory Holdings (CGH), a partner with both strength and experience, as our strategic investor. The company will focus on the antibacterial market for healthcare, infants, and the elderly in the future. CGH’s involvement will help us explore more diverse applications and markets. Hong Kong will continue to serve as the R&D headquarters and certification centre, with complementary strengths between Hong Kong and mainland China working in synergy.”
Mr Stanley Chan, CEO of Central Glory Holdings (CGH), expressed confidence in the partnership: “We have great confidence in the IMU+® organic-based antibacterial raw material. We will assist IML in establishing a mainland subsidiary and expanding the application of IMU+® from 3D printing materials to leather and stone materials. We also welcome other industry players to collaborate in developing the next generation of antibacterial materials.”
Technological Innovation Leading a New Direction for Health
Since its establishment in 2021 by Professors Chris K. Y. Lo and C. W. Kan from The Hong Kong Polytechnic University, Immune Materials Limited (IML) has been dedicated to research in healthcare sciences. The team successfully developed IMU+®, an organic-based, metal-free antibacterial material which effectively eliminates bacteria, viruses, and fungi on surfaces, reducing the risk of infection and transmission.
, an
Currently, 3D-printed products incorporating IMU+® have been successfully adopted in the Intensive Care Units of hospitals under the Hong Kong Hospital Authority, as well as in Hong Kong government offices and public spaces, safeguarding public health and safety. This innovative technology provides safer and healthier solutions for everyday life.
Strategic Layout for a Shared Future
Since its establishment in 2023, Central Glory Holdings (CGH) has adhered to its mission of “deeply engaging in Fujian, connecting with the world,” with operations spanning next-generation office spaces, regional trade, youth cultural tourism, and capital and incubation. This collaboration with IML is a key part of its strategic layout.
IML will continue to drive sustainable and healthy corporate development through technological innovation, refining production-sales integration, prioritising product quality, and pursuing a path of innovation-driven, resource-efficient, and environmentally friendly sustainable development. This partnership with CGH will further enhance the company’s market competitiveness.
Looking ahead, both parties will fully leverage their respective strengths to jointly advance the innovation and application of antibacterial material technologies, contributing more to global health initiatives.
